AI assistant
Sending…
CASTLE BIOSCIENCES INC — Director's Dealing 2019
Dec 17, 2019
32601_dirs_2019-12-17_304be49b-fce0-497b-aa1d-8b8a697352a9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2019-12-13
Reporting Person: Spiess Bernhard E. (Chief Business Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 | Stock option (right to buy) | $29.5 | A | 35000 | Acquired | 2029-12-12 | Common Stock (35000.0) | Direct |
Footnotes
F1: 25% of the shares shall vest on December 13, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter.
More from CASTLE BIOSCIENCES INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 26
Annual Report
2026
Feb 26
Earnings Release
2026
Feb 26
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Jan 22